Edwards' Sapien 3 Ultra Transcatheter Heart Valve Receives FDA Approval

2019-01-08 10:06:11 Itn

Edwards Lifesciences Corp. announced that the Sapien 3 Ultra system has received U.S. Food and Drug Administration (FDA) approval for transcatheter aortic valve replacement (TAVR) in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery.

閱讀全文
  • 相關廠商

    無相關廠商